» Articles » PMID: 28980775

Long-Term Recovery After Endothelial Colony-Forming Cells or Human Umbilical Cord Blood Cells Administration in a Rat Model of Neonatal Hypoxic-Ischemic Encephalopathy

Overview
Date 2017 Oct 6
PMID 28980775
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Neonatal hypoxic-ischemic encephalopathy (NHIE) is a dramatic perinatal complication, associated with poor neurological prognosis despite neuroprotection by therapeutic hypothermia, in the absence of an available curative therapy. We evaluated and compared ready-to-use human umbilical cord blood cells (HUCBC) and bankable but allogeneic endothelial progenitors (ECFC) as cell therapy candidate for NHIE. We compared benefits of HUCBC and ECFC transplantation 48 hours after injury in male rat NHIE model, based on the Rice-Vannucci approach. Based on behavioral tests, immune-histological assessment and metabolic imaging of brain perfusion using single photon emission computed tomography (SPECT), HUCBC, or ECFC administration provided equally early and sustained functional benefits, up to 8 weeks after injury. These results were associated with total normalization of injured hemisphere cerebral blood flow assessed by SPECT/CT imaging. In conclusion, even if ECFC represent an efficient candidate, HUCBC autologous criteria and easier availability make them the ideal candidate for hypoxic-ischemic cell therapy. Stem Cells Translational Medicine 2017;6:1987-1996.

Citing Articles

Mononuclear cell therapy of neonatal hypoxic-ischemic encephalopathy in preclinical versus clinical studies: a systematic analysis of therapeutic efficacy and study design.

Scrutton A, Ollis F, Boltze J Neuroprotection. 2024; 1(2):143-159.

PMID: 38213793 PMC: 7615506. DOI: 10.1002/nep3.29.


Stem cell-based interventions for the treatment of stroke in newborn infants.

Bruschettini M, Badura A, Romantsik O Cochrane Database Syst Rev. 2023; 11:CD015582.

PMID: 37994736 PMC: 10666199. DOI: 10.1002/14651858.CD015582.pub2.


The alternative 3' splice site of may promote neuronal survival after neonatal hypoxic-ischemic encephalopathy injury.

Chen G, Yan S, Zhang J, Zhang J, Deng I, He R Ibrain. 2023; 8(3):302-313.

PMID: 37786733 PMC: 10529014. DOI: 10.1002/ibra.12056.


Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury: A Systematic Review & Meta-Analysis of Preclinical Studies.

Nguyen T, Purcell E, Smith M, Penny T, Paton M, Zhou L Int J Mol Sci. 2023; 24(5).

PMID: 36901781 PMC: 10001969. DOI: 10.3390/ijms24054351.


Factors Influencing the Efficacy of Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury.

Purcell E, Nguyen T, Smith M, Penny T, Paton M, Zhou L Stem Cells Transl Med. 2023; 12(3):125-139.

PMID: 36847059 PMC: 10021495. DOI: 10.1093/stcltm/szad006.


References
1.
Fan L, Lin S, Pang Y, Lei M, Zhang F, Rhodes P . Hypoxia-ischemia induced neurological dysfunction and brain injury in the neonatal rat. Behav Brain Res. 2005; 165(1):80-90. DOI: 10.1016/j.bbr.2005.06.033. View

2.
Azzopardi D, Strohm B, Edwards A, Dyet L, Halliday H, Juszczak E . Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009; 361(14):1349-58. DOI: 10.1056/NEJMoa0900854. View

3.
Bae S, Kong T, Lee H, Kim K, Hong K, Chopp M . Long-lasting paracrine effects of human cord blood cells on damaged neocortex in an animal model of cerebral palsy. Cell Transplant. 2012; 21(11):2497-515. DOI: 10.3727/096368912X640457. View

4.
Kaur C, Rathnasamy G, Ling E . Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J Neuroimmune Pharmacol. 2012; 8(1):66-78. DOI: 10.1007/s11481-012-9347-2. View

5.
Ingram D, Mead L, Tanaka H, Meade V, Fenoglio A, Mortell K . Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004; 104(9):2752-60. DOI: 10.1182/blood-2004-04-1396. View